USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
E.P., LTD
Address:
35 MEDFORD STREET
SUITE 204
SOMERVILLE, MA 02143
Phone:
(617) 623-3157
URL:
N/A
EIN:
43264695
DUNS:
884074444
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $389,542.00 6
SBIR Phase II $4,154,378.00 2

Award List:

COMPARISON OF ADAPTIVE METHODS TO REMOVE MOTION ARTIFACT

Award Year / Program / Phase:
1999 / SBIR / Phase I
Award Amount:
$100,000.00
Agency:
HHS
Principal Investigator:
Patrick S. Hamilton
Abstract:
N/a

NOVEL CATHETER FOR TREATMENT OF VENTRICULAR TACHYCARDIA

Award Year / Program / Phase:
1999 / SBIR / Phase I
Award Amount:
$89,530.00
Agency:
HHS
Principal Investigator:
Michael G. Curley
Abstract:
N/a

N/A

Award Year / Program / Phase:
2000 / SBIR / Phase I
Award Amount:
$100,012.00
Agency:
HHS
Principal Investigator:
Patrick S. Hamilton
Abstract:
Not Available The main motivation for a reconfigurable collision avoidance system is greater survivability, possible if the feedback system can reorganize itself in the presence of obstacles, actuator failures and surface damages. This project develops an autonomous in

N/A

Award Year / Program / Phase:
2000 / SBIR / Phase I
Award Amount:
$100,000.00
Agency:
HHS
Principal Investigator:
Patrick S. Hamilton
Abstract:
N/a

N/A

Award Year / Program / Phase:
2000 / SBIR / Phase I
Award Amount:
$0.00
Agency:
HHS
Principal Investigator:
Michael G. Curley
Abstract:
N/a

N/A

Award Year / Program / Phase:
2000 / SBIR / Phase II
Award Amount:
$475,399.00
Agency:
HHS
Principal Investigator:
Michael G. Curley
Abstract:
N/a

NOVEL CATHETER FOR TREATMENT OF VENTRICULAR TACHYCARDIA

Award Year / Program / Phase:
2002 / SBIR / Phase I
Award Amount:
$0.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Sudden cardiac death kills 300,000 people in the United States yearly. More than half of these deaths are caused by arrhythmias including ventricular tachycardia. Radiofrequency ablation, which successfully treats supraventricular tachycardia, is not successful… More

NOVEL CATHETER FOR TREATMENT OF VENTRICULAR TACHYCARDIA

Award Year / Program / Phase:
2008 / SBIR / Phase II
Award Amount:
$3,678,979.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Ischemic ventricular tachycardia (VT) is a contributing cause to more than half of the 300,000 sudden cardiac deaths that occur annually in the United States. Implantable cardioverter defibrillators (ICDs) are the stand ard therapy but they are expensive the… More